🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
313,52 USD
Máx. histórico
322,75
4 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-2,86%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,12%
Cierre anterior
307,02
Rango de hoy
309,46 – 317,76
Volumen hoy
195.564
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 33,04 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 350,92 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 7 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 07/10/2025 | 183,76 | 183,76 | 179,40 | 183,16 | +0,30% | 2,37% | 98.000 |
| 06/10/2025 | 182,00 | 184,26 | 181,45 | 182,61 | +0,90% | 1,54% | 170.900 |
| 03/10/2025 | 180,12 | 183,81 | 179,21 | 180,99 | +0,48% | 2,55% | 145.700 |
| 02/10/2025 | 179,27 | 182,65 | 175,56 | 180,12 | +0,58% | 3,95% | 219.300 |
| 01/10/2025 | 176,68 | 181,70 | 176,68 | 179,08 | +1,10% | 2,84% | 184.900 |
| 30/09/2025 | 173,23 | 177,81 | 172,36 | 177,14 | +2,32% | 3,15% | 187.700 |
| 29/09/2025 | 169,72 | 173,35 | 166,10 | 173,13 | +2,01% | 4,27% | 217.100 |
| 26/09/2025 | 167,87 | 171,55 | 166,54 | 169,72 | +1,78% | 2,98% | 177.400 |
| 25/09/2025 | 168,04 | 168,04 | 163,45 | 166,76 | -1,30% | 2,73% | 103.700 |
| 24/09/2025 | 170,77 | 171,90 | 167,63 | 168,96 | -0,99% | 2,50% | 127.300 |
| 23/09/2025 | 171,03 | 172,30 | 169,81 | 170,65 | -0,07% | 1,46% | 133.800 |
| 22/09/2025 | 167,38 | 172,45 | 164,90 | 170,77 | +2,56% | 4,51% | 256.800 |
| 19/09/2025 | 170,26 | 170,58 | 165,45 | 166,51 | -1,95% | 3,01% | 587.000 |
| 18/09/2025 | 165,53 | 170,78 | 165,13 | 169,83 | +2,67% | 3,41% | 357.700 |
| 17/09/2025 | 166,68 | 169,23 | 163,50 | 165,41 | -0,50% | 3,44% | 368.900 |
| 16/09/2025 | 164,33 | 166,80 | 163,10 | 166,24 | +0,43% | 2,25% | 388.600 |
| 15/09/2025 | 165,63 | 166,68 | 161,82 | 165,52 | -0,14% | 2,93% | 315.500 |
| 12/09/2025 | 166,28 | 167,07 | 163,07 | 165,75 | -0,78% | 2,41% | 298.600 |
| 11/09/2025 | 166,84 | 169,00 | 165,00 | 167,06 | +0,66% | 2,40% | 193.700 |
| 10/09/2025 | 165,01 | 166,96 | 163,48 | 165,97 | +0,34% | 2,11% | 141.700 |
| 09/09/2025 | 165,76 | 167,98 | 162,74 | 165,41 | -0,27% | 3,16% | 252.800 |
| 08/09/2025 | 167,50 | 169,13 | 165,21 | 165,86 | -0,53% | 2,34% | 124.500 |
| 05/09/2025 | 167,86 | 169,49 | 166,07 | 166,75 | -0,59% | 2,04% | 194.000 |
| 04/09/2025 | 166,68 | 168,50 | 166,49 | 167,74 | +0,72% | 1,21% | 122.000 |
| 03/09/2025 | 164,40 | 166,99 | 164,28 | 166,54 | +1,72% | 1,65% | 191.000 |
| 02/09/2025 | 161,71 | 164,67 | 160,80 | 163,73 | +1,25% | 2,39% | 147.300 |
| 29/08/2025 | 161,35 | 163,34 | 160,05 | 161,71 | +1,09% | 2,04% | 147.000 |
| 28/08/2025 | 158,40 | 161,35 | 158,40 | 159,96 | +0,54% | 1,86% | 151.400 |
| 27/08/2025 | 159,37 | 161,89 | 158,78 | 159,10 | -0,41% | 1,95% | 140.500 |
| 26/08/2025 | 158,80 | 160,48 | 158,13 | 159,76 | +0,61% | 1,48% | 102.100 |